Zhejiang Lions are closely watching the latest development in the 2025-2026 CBA playoffs as Shanghai Sharks foreign center Hassan Niam Whiteside faces a doping ban. The suspension could alter the championship outcome and directly affect the Lions' path to the next round.
What happened?
China Anti-Doping Agency (Chinada) announced on May 6 that Whiteside tested positive for oxandrolone metabolites and clomifene during the playoff home game against Shandong Hi-Speed Kirin. He waived his right to a B‑sample test. Under the World Anti-Doping Agency (WADA) prohibited list, oxandrolone metabolites are classified as S1 anabolic agents, while clomifene falls under S4 hormone and metabolic modulators.
How does it affect Shanghai Sharks' title?
Despite playing the second game of the Shandong series and the entire semi‑final against Beijing Ducks, Whiteside missed the finals against Zhejiang Lions. Shanghai Sharks still won the championship 4‑1. Officials said the team will keep the title; the ban applies only to the player.
What does this mean for Zhejiang Lions?
Zhejiang Lions fell 84‑78 in the first finals game but maintained a strong defensive rating, averaging 12.3 rebounds per game. The doping case has heightened league scrutiny on officiating and testing protocols, likely leading to stricter enforcement. For the Lions, sustaining defensive intensity and improving three‑point shooting (36.5% this season) will be vital.
What’s next?
China Anti‑Doping Agency expects to issue a formal sanction within the month, potentially a two‑year ban. If enforced, Shanghai Sharks will lose their interior anchor for the next season and may reshuffle the roster. Zhejiang Lions could capitalize on the void to chase a higher playoff seed, while the league considers tighter testing to protect its credibility.